Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia. Herishanu Y, Avivi I, Aharon A, Shefer G, et al. Blood 2021 Apr 16. pii: 475742. doi: 10.1182/blood.2021011568.

Read + Share

Amedeo Smart

Independent Medical Education

Herishanu Y, Avivi I, Aharon A, Shefer G, et al. Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia. Blood 2021 Apr 16. pii: 475742. doi: 10.1182/blood.2021011568.
PMID: 33861303